BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 10523648)

  • 1. Structural and functional cross-talk between a distant enhancer and the epsilon-globin gene promoter shows interdependence of the two elements in chromatin.
    McDowell JC; Dean A
    Mol Cell Biol; 1999 Nov; 19(11):7600-9. PubMed ID: 10523648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5' hypersensitive site 2 of the beta-globin locus control region.
    Gong QH; McDowell JC; Dean A
    Mol Cell Biol; 1996 Nov; 16(11):6055-64. PubMed ID: 8887635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A major role for the TATA box in recruitment of chromatin modifying complexes to a globin gene promoter.
    Gui CY; Dean A
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7009-14. PubMed ID: 12773626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of transcriptional activator GATA-1 at human beta-globin HS2.
    Cho Y; Song SH; Lee JJ; Choi N; Kim CG; Dean A; Kim A
    Nucleic Acids Res; 2008 Aug; 36(14):4521-8. PubMed ID: 18586828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro.
    Armstrong JA; Emerson BM
    Mol Cell Biol; 1996 Oct; 16(10):5634-44. PubMed ID: 8816476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitive site 2 specifies a unique function within the human beta-globin locus control region to stimulate globin gene transcription.
    Bungert J; Tanimoto K; Patel S; Liu Q; Fear M; Engel JD
    Mol Cell Biol; 1999 Apr; 19(4):3062-72. PubMed ID: 10082573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of functional elements of the chicken epsilon-globin promoter involved in stage-specific interaction with the beta/epsilon enhancer.
    Mason MM; Grasso JA; Gavrilova O; Reitman M
    J Biol Chem; 1996 Oct; 271(41):25459-67. PubMed ID: 8810316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human β-globin enhancer LCR HS2 plays a role in forming a TAD by activating chromatin structure at neighboring CTCF sites.
    Kim J; Kang J; Kim YW; Kim A
    FASEB J; 2021 Jun; 35(6):e21669. PubMed ID: 34033138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-globin gene promoter elements required for interaction with globin enhancers.
    Langdon SD; Kaufman RE
    Blood; 1998 Jan; 91(1):309-18. PubMed ID: 9414299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for utilization of CREB binding protein by hypersensitive site two of the beta-globin locus control region.
    Johnson KD; Norton JE; Bresnick EH
    Nucleic Acids Res; 2002 Apr; 30(7):1522-30. PubMed ID: 11917012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer activity of upstream hypersensitive site 2 of the chicken beta-globin cluster is mediated by GATA sites.
    Abruzzo LV; Reitman M
    J Biol Chem; 1994 Dec; 269(51):32565-71. PubMed ID: 7798259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancer-dependent transcription of the epsilon-globin promoter requires promoter-bound GATA-1 and enhancer-bound AP-1/NF-E2.
    Gong Q; Dean A
    Mol Cell Biol; 1993 Feb; 13(2):911-7. PubMed ID: 8423810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximal activity of an erythroid-specific enhancer requires the presence of specific protein binding sites in linked promoters.
    Amrolia PJ; Gabbard W; Cunningham JM; Jane SM
    J Biol Chem; 1998 May; 273(22):13593-8. PubMed ID: 9593696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNase I hypersensitivity and epsilon-globin transcriptional enhancement are separable in locus control region (LCR) HS1 mutant human beta-globin YAC transgenic mice.
    Shimotsuma M; Okamura E; Matsuzaki H; Fukamizu A; Tanimoto K
    J Biol Chem; 2010 May; 285(19):14495-503. PubMed ID: 20231293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of human beta-globin locus control region hypersensitive sites in the absence of chromatin assembly.
    Leach KM; Nightingale K; Igarashi K; Levings PP; Engel JD; Becker PB; Bungert J
    Mol Cell Biol; 2001 Apr; 21(8):2629-40. PubMed ID: 11283243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A (GATA)(7) motif located in the 5' boundary area of the human beta-globin locus control region exhibits silencer activity in erythroid cells.
    Ramchandran R; Bengra C; Whitney B; Lanclos K; Tuan D
    Am J Hematol; 2000 Sep; 65(1):14-24. PubMed ID: 10936858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct interaction of NF-E2 with hypersensitive site 2 of the beta-globin locus control region in living cells.
    Forsberg EC; Downs KM; Bresnick EH
    Blood; 2000 Jul; 96(1):334-9. PubMed ID: 10891470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: the effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer.
    Miller JL; Walsh CE; Ney PA; Samulski RJ; Nienhuis AW
    Blood; 1993 Sep; 82(6):1900-6. PubMed ID: 8400240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple elements in human beta-globin locus control region 5' HS 2 are involved in enhancer activity and position-independent, transgene expression.
    Caterina JJ; Ciavatta DJ; Donze D; Behringer RR; Townes TM
    Nucleic Acids Res; 1994 Mar; 22(6):1006-11. PubMed ID: 8152905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation of human zeta 2 globin promoter by the alpha globin regulatory element (HS-40): functional role of specific nuclear factor-DNA complexes.
    Zhang Q; Reddy PM; Yu CY; Bastiani C; Higgs D; Stamatoyannopoulos G; Papayannopoulou T; Shen CK
    Mol Cell Biol; 1993 Apr; 13(4):2298-308. PubMed ID: 8455611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.